Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a gene therapy vector for blood disorders like sickle cell disease
A potentially safer, more effective gene therapy vector for blood disorders

besthealthtale.com
Home »
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a gene therapy vector for blood disorders like sickle cell disease
Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable mutations in their DNA damage-repair
Bacteria may be involved in the development of type 2 diabetes, according to a study published today in Nature Metabolism
The increasingly popular practice of ‘vaginal seeding’—in which cesarean-delivered babies are immediately swabbed with the mother’s vaginal fluids—is declared unjustified